Medication for medullary thyroid cancer in final stage of development
medrev 2017-04-26T12:35:16+00:00Cabozantinib, a medication for the treatment of medullary thyroid cancer, has shown promising results in final-stage testing. Until now, there was no medication available in Belgium for treating this rare form of thyroid cancer. Dr. Patrick Schöffski, professor of oncology at the University of Leuven (KU Leuven), presented the results at the annual meeting of [...]